The Vienna Drosophila Resource Center (VDRC) is part of the Vienna Biocenter Core Facilities (VBCF), a publicly funded, non profit research infrastructure.
View this resource Bookmark this resourcePreclinical Studies
In this section you may find relevant information regarding the safety, efficacy and toxicology of the drugs actually used for Rare Diseases as well as:
Good Laboratory Practices (GLPs),
Animal models: juvenile, humanised animal models, disease specific animal models and documents that may support you to correctly use animal models from ethical points of view.
Proof of principle
In silico modelling
EATRIS Regulatory support
Published by n/a
Orphan Drug DesignationRegulatory SupportEATRISScientic adviceThrough a combination of in-house and external partnerships with a range of regulatory experts and groups, EATRIS can provide regulatory support for most types of product including: Expert opinion, Orphan Drug Designation and Scientific Advice application at the EMA, Pre-clinical and clinical plan development, Informal scientific advice with selected national competent authorities, for highly complex projects,
access to EATRIS Regulatory Database (free of charge) that contains information about the regulatory requirements, guidelines and legislations from 27 EU countries (as well as Norway, Switzerland, Turkey and Israel) regarding drug and medical device development derived from the application of European legislation.